Company Filing History:
Years Active: 2007-2009
Title: Martin Lang: Innovator in Benzazole Compounds
Introduction
Martin Lang is a notable inventor based in Graefelfing, Germany. He has made significant contributions to the field of chemistry, particularly in the development of benzazole analogues. With a total of 3 patents to his name, Lang's work focuses on innovative compounds that have potential applications in medical treatments.
Latest Patents
Lang's latest patents include groundbreaking inventions related to benzazole compounds. One of his notable patents is titled "Benzazole analogues and uses thereof," which pertains to compounds characterized by specific general formulas and their physiologically functional derivatives. Another significant patent is also titled "Benzazole analogues and uses thereof," which describes N-heteroaryl-benzazole-2,(5 or 6)-diamine derivatives. These derivatives are recognized for their potential as protein kinase inhibitors, particularly in the treatment of cancer.
Career Highlights
Martin Lang is currently associated with 4SC AG, a company that focuses on the development of innovative therapies for cancer and autoimmune diseases. His work at 4SC AG has allowed him to explore and develop new chemical compounds that could lead to significant advancements in medical treatments.
Collaborations
Lang has collaborated with esteemed colleagues such as Thomas Herz and Rolf Krauss. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Martin Lang's contributions to the field of chemistry, particularly through his patents on benzazole analogues, highlight his innovative spirit and dedication to advancing medical science. His work continues to pave the way for potential breakthroughs in cancer treatment.